"Identification": "Mrs. Evelyn Reed, a 68-year-old female, presents today for a routine follow-up appointment. She has a history of Stage III HER2-positive breast cancer, diagnosed in March 2022. She underwent a lumpectomy, followed by chemotherapy with docetaxel, carboplatin, and trastuzumab. She completed radiation therapy in September 2022. Her recent PET scan in August 2024 showed no evidence of disease."
"Reason for Visit": "Mrs. Reed is here today for a follow-up to discuss her ongoing treatment with pertuzumab and trastuzumab, and to assess for any side effects or concerns. She is accompanied by her daughter, Sarah. No interpreter was required."
"Consent": "The patient provided verbal consent to use the AI scribe during this visit, understanding its purpose, potential benefits, and any associated privacy and security risks"
"steroids": "Dexamethasone 4mg orally twice daily."
"anti-epileptic": "Keppra 500mg twice daily, no history of seizures."
"Interval History": "Since her last visit, Mrs. Reed reports feeling well, with no significant changes in her overall well-being. She denies any new symptoms. She reports mild fatigue, which she attributes to her ongoing treatment. She is able to perform all her activities of daily living without difficulty."
"Living Situation": "Mrs. Reed lives at home with her husband. She is able to manage her own care and requires no assistance with daily activities."
"Physical Exam":
"ECOG performance status": "1 (Capable of light housework, but unable to work.)"
"Neurological Exam": "Neurological exam is within normal limits. Cranial nerves II-XII grossly intact. Strength 5/5 in all extremities. Sensation intact to light touch and pinprick. No pronator drift. Finger-to-nose and heel-to-shin testing are normal. Gait is steady."
"Assessment/Plan": "Mrs. Reed continues to do well on her current treatment regimen. Her physical exam is stable and she reports no new symptoms. The plan is to continue pertuzumab and trastuzumab as scheduled. Dexamethasone is indicated to manage any side effects from the chemotherapy."
"Treatment Plan": "Continue pertuzumab 840mg IV every 3 weeks and trastuzumab 600mg SC every 3 weeks. Dexamethasone 4mg orally twice daily. Cycle length is 21 days. Potential toxicities include fatigue, nausea, and myelosuppression. Patient consents to the treatment plan."
"Follow-up Plan": "Next appointment in 3 weeks for treatment. Repeat blood work prior to each treatment cycle. Schedule a follow-up PET scan in 6 months."
"Document Footer": "This document was created using AI Ambient Scribe and Front-End Speech Recognition software and may include incorrect spelling/words. Consent for usage of AI was obtained by patient/guardian."
Identification
[describe patient demographics, relevant past medical history, and key diagnostic findings related to their primary condition, including pathology results and previous treatments with dates] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
[describe the reason for the current visit and who accompanied the patient, including any interpreter details] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
**Consent**
"The patient provided verbal consent to use the AI scribe during this visit, understanding its purpose, potential benefits, and any associated privacy and security risks"
steroids:
[document current steroid use, including dosage and frequency] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write as a single line of text.)
anti-epileptic:
[document current anti-epileptic medication use, including dosage, frequency, and any history of seizures] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write as a single line of text.)
Interval History
[summarize changes in patient's symptoms, functional status, and overall well-being since the last visit, including any new or resolved issues and their impact on daily life] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
[document the patient's living situation and who they reside with] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
Physical Exam
ECOG performance status: [document the patient's ECOG performance status with a numerical score and a description of their functional abilities] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write as a single line of text.)
[describe neurological exam findings, cognition assessment, including speech, extraocular movements (EOM), cranial nerve (CN) assessment, strength, sensation, pronator drift, finger-to-nose (FTN) test, and gait] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
Assessment/Plan
[provide a concise assessment of the patient's current condition, linking it to the interval history and physical exam findings, and state the rationale for any current treatment decisions, including whether dexamethasone is indicated] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
[detail the proposed treatment plan, including medication name, administration route, dosage, cycle length, potential toxicities, and confirmation of patient consent] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
[outline the follow-up plan, including the timing of subsequent appointments and any scheduled imaging or investigations] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit section entirely. Write in a single paragraph of full sentences.)
"This document was created using AI Ambient Scribe and Front-End Speech Recognition software and may include incorrect spelling/words. Consent for usage of AI was obtained by patient/guardian."
(Never come up with your own patient details, assessment, plan, interventions, evaluation, or plan for continuing care - use only the transcript, contextual notes, or clinical note as a reference for the information included in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes, or clinical note, you must not state the information has not been explicitly mentioned in your output, just leave the relevant placeholder or omit the placeholder completely. Use as many lines, paragraphs, or bullet points, depending on the format, as needed to capture all the relevant information from the transcript.)